These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9350683)

  • 1. Resistance of the parathyroid glands to vitamin D in renal failure: implications for medical management.
    Fukagawa M; Kitaoka M; Kurokawa K
    Kidney Int Suppl; 1997 Nov; 62():S60-4. PubMed ID: 9350683
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance of parathyroid cell to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure.
    Fukagawa M; Fukuda N; Yi H; Kurokawa K
    Nephrol Dial Transplant; 1995; 10(3):316-9. PubMed ID: 7792025
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperparathyroid and hypoparathyroid disorders.
    Marx SJ
    N Engl J Med; 2000 Dec; 343(25):1863-75. PubMed ID: 11117980
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis of parathyroid hyperplasia in renal failure.
    Cozzolino M; Brancaccio D; Gallieni M; Galassi A; Slatopolsky E; Dusso A
    J Nephrol; 2005; 18(1):5-8. PubMed ID: 15772917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of calcium and bone metabolism in chronic renal failure.
    Avioli LV
    Mod Treat; 1970 May; 7(3):675-85. PubMed ID: 4920810
    [No Abstract]   [Full Text] [Related]  

  • 7. Parathyroid glands in calcium regulation and human disease.
    Akerström G; Hellman P; Hessman O; Segersten U; Westin G
    Ann N Y Acad Sci; 2005 Apr; 1040():53-8. PubMed ID: 15891005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D therapy for chronic kidney disease.
    Bhan I; Thadhani R
    Semin Nephrol; 2009 Jan; 29(1):85-93. PubMed ID: 19121478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.
    Dusso A; Cozzolino M; Lu Y; Sato T; Slatopolsky E
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):507-11. PubMed ID: 15225829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of secondary hyperparathyroidism in renal failure: basic and clinical aspects.
    Fukagawa M; Iwasaki Y
    Nephrol Dial Transplant; 1999; 14 Suppl 1():61-2. PubMed ID: 10048454
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland.
    Parfitt AM
    Miner Electrolyte Metab; 1982 Aug; 8(2):92-112. PubMed ID: 6762496
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis and management of parathyroid hyperplasia in chronic renal failure: role of calcitriol.
    Fukagawa M; Kitaoka M; Fukuda N; Yi H; Kurokawa K
    Miner Electrolyte Metab; 1995; 21(1-3):97-100. PubMed ID: 7565473
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular basis for the management of secondary hyperparathyroidism in chronic renal failure.
    Fukagawa M; Yi H; Fukuda N; Kurokawa K
    Artif Organs; 1995 Dec; 19(12):1210-4. PubMed ID: 8967876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The parathyroids and calcitonin. Study of its clinical physiology. II. Thyrocalcitonin and vitamin D; metabolic actions; study of its physiopathology].
    Garrido B; Jiménez JA; Damiano A; Betancort P; Macías A
    Rev Iber Endocrinol; 1971; 18(103):49-82. PubMed ID: 4931027
    [No Abstract]   [Full Text] [Related]  

  • 15. Normocalcemic secondary hyperparathyroidism and malabsorption.
    Fischer JA; Binswanger U; Schenk R; Merz W; Kistler HJ
    Helv Med Acta; 1969 May; 35(1):30-42. PubMed ID: 5772693
    [No Abstract]   [Full Text] [Related]  

  • 16. The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia.
    Mak RH; Wong JH
    Miner Electrolyte Metab; 1992; 18(2-5):156-9. PubMed ID: 1465050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of calcium and magnesium in the secretion and the synthesis of parathyroid hormone at the cellular level].
    Fournier A; Yverneau-Hardy P; Ghazali A; Oprisiu R; Hottelart C; Said S; Westeel PF; Achard JM; Pruna A
    Presse Med; 1998 Sep; 27(26):1338-48. PubMed ID: 9779055
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
    Buchwald PC; Westin G; Akerström G
    Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid autografts--morphology and function: six years' experience with parathyroid autotransplantation in uremic patients.
    Klempa I; Frei U; Röttger P; Schneider M; Koch KM
    World J Surg; 1984 Aug; 8(4):540-4. PubMed ID: 6485351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.